DUBLIN--(BUSINESS WIRE)--The "Isothermal Nucleic Acid Amplification Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
The global isothermal nucleic acid amplification technology market grew at a CAGR of around 10% during 2014-2019. Looking forward, the global isothermal nucleic acid amplification technology market to continue its strong growth during the next five years.
The isothermal nucleic acid amplification technology (INAAT) is used in the field of molecular biology and recombinant DNA technologies for detecting and analyzing nucleic acids. This technique is commonly used for DNA, RNA, cells, proteins, small molecules and ions to ensure the rapid, sensitive and accurate diagnosis of infectious, genetic and inherited diseases.
The amplicons generated from this technique are used for producing versatile nucleic acid nanomaterials that are widely utilized in biomedicine, bioimaging and biosensing. They are also used for the detection of various infectious diseases, such as (HIV), tuberculosis, influenza, hepatitis A and B, chlamydia and gonorrhea (CT/NG).
One of the leading trends in the global market is the ongoing development of INAAT for the detection of the coronavirus disease (COVID-19), as it can be conducted at room temperature, without the need for specialized laboratory equipment.
Furthermore, the increasing prevalence of cancer and other chronic medical ailments, along with the rising demand for efficient diagnosis and treatment alternatives, is also providing a boost to the market growth. In line with this, the widespread adoption of Loop-mediated Isothermal Amplification (LAMP) tests that are used for the amplification of both DNA and RNA, along with the identification of genetically modified organisms (GMOs) is driving the product demand further.
Additionally, various technological advancements, such as the development of Strand Displacement Amplification (SDA), Single Primer Isothermal Amplification (SPIA) and Recombinase Polymerase Amplification (RPA), is acting as another growth-inducing factor.
Other factors, including the rising geriatric population across the globe, coupled with extensive research and development (R&D) activities in the field of microbiology and significant growth in the healthcare infrastructure, are projected to drive the market further.
Key Questions Answered in This Report:
- How has the global isothermal nucleic acid amplification technology market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the isothermal nucleic acid amplification technology market?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global isothermal nucleic acid amplification technology market and who are the key players?
- What is the degree of competition in the industry?
Key Topics Covered:
2 Scope and Methodology
2.1 Objectives of the Study
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology
3 Executive Summary
4.2 Key Industry Trends
5 Global Isothermal Nucleic Acid Amplification Technology Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of Covid-19
5.4 Market Forecast
6 Market Breakup by Product
7 Market Breakup by Technology
7.1 Helicase-Dependent Amplification (HDA)
7.2 Nicking Enzyme Amplification Reaction (NEAR)
7.3 Loop-Mediated Isothermal Amplification (LAMP)
7.4 Strand Displacement Amplification (SDA)
7.5 Nucleic Acid Sequence-Based Amplification (NASBA)
7.6 Transcription Mediated Amplification (TMA)
7.7 Single Primer Isothermal Amplification (SPIA)
8 Market Breakup by Application
8.1 Infectious Disease Diagnosis
8.1.1 Market Trends
8.1.2 Major Types
8.1.3 Market Forecast
8.2 Blood Screening
9 Market Breakup by End-User
9.2 Diagnostic Laboratories
9.3 Research Laboratories
10 Market Breakup by Region
11 SWOT Analysis
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- Abbott Laboratories
- BD (Becton, Dickinson and Company)
- Eiken Chemical Co. Ltd.
- Hologic Inc.
- Meridian Bioscience Inc.
- OptiGene Limited
- Thermo Fisher Scientific Inc.
- Tecan Trading AG
- Ustar Biotechnologies Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/guld1s